摘要
目的 :探讨雷公藤多苷片在小儿原发性和继发性肾病综合征治疗中的价值及降低肾性蛋白尿的作用。方法 :选择近 4年来 3 0例病人 ,全部经肾活检确定病理类型。口服雷公藤多苷片 1 .5mg·kg- 1 ·d- 1 ,共 4wk ,观察浮肿消退 ,尿量增减及消化道反应 ,定期检查 2 4h尿蛋白定量、肝肾功能、外周血象及血浆蛋白变化。结果 :3 0例中 1 4例得到缓解 ,1 2例改善 ,有效共 2 6例 ,占 86.7% ,其中治疗 1wk后有效 7例 ,2wk后有效 9例 ,4wk后无效 4例 ,3 0例中仅有个别轻度消化道症状 ,少数病人治疗初期血清谷丙转氨酶 (ALT)轻度上升 ,继续治疗后恢复 ,有3例在整个治疗过程中白细胞降至 3 .5× 1 0 9·L- 1 ,但均未影响疗程 ,所有病人肾功能均正常。结论 :雷公藤多苷能有效降低小儿肾性蛋白尿 。
AIM: To investigate the value and the effect of tripterygium wilfordii on decreasing proteinuria in the primary and secondary nephropathy synd rome in children. METHODS: 30 patients were confirmed the pathol ogy classification, and given tablets of tripterygium wilfordii by 1.5 kg·d -1 for 4 weeks. 24-hour urine volume and gastrointestinal reaction were obser ved, and regularly the 24-hour proteinuria quantity, hepatic and renal function , peripheral blood, and serum albumin were examined. RESULTS: 14 of 30 patients were effective after the treatment, 12 patients were improved, 7 patients were effective after 1-week treatment, and 9 patients were effective after 2 weeks. Individual patients had moderate gastrointestinal disorder; a few patients had modest ALT increase in early therapy; and all recovered after cont inuous treatment. The value of WBC in 3 patients decreased to 3.5 ×10 9 L -1 in the whole course, but, it did not affected the administration. A ll patients had normal renal function. CONCLUSIONS: Tripterygi um wuilfordii can effectively decrease proteinuria, and improve the symptom of primary and secondary nephropathy syndrome in children.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2003年第3期336-338,共3页
Chinese Journal of Clinical Pharmacology and Therapeutics
